Overview

Study Evaluating the Effects of AIR645 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy of inhaled AIR645 in the suppression of the Asthmatic Responses in subjects with mild asthma inhaling an allergen.
Phase:
Phase 2
Details
Lead Sponsor:
Altair Therapeutics, Inc.
Treatments:
Pharmaceutical Solutions